Children with CLN2 disease

Goals of management

Experts have identified CLN2-­specific disease management strategies that can greatly impact patient outcomes

CLN2 disease management support starts with a multidisciplinary care team

Multiple specialities can work together to provide optimal outcomes for children with CLN2 disease. This approach to optimise care is essential for patients and families.1

CLN2 disease multidisciplinary care team

CLN2-specific care aims to maintain function for as long as possible and address quality of life

The goals of CLN2 disease care should evolve as the disease progresses

Experts have noted that reassessing the goals of care and management is important throughout the course of the disease.1

  • Early in the disease: Goals strive to maintain function for as long as possible
  • Later in the disease: Goals evolve toward maintenance of quality of life and pain control as functions are lost
CLN2 disease management goals
Understanding the needs of families across the spectrum of care can make an important difference in the approach to CLN2-specific management strategies.1
CLN2 disease-specific care

Although these are CLN2 disease-specific management strategies, some may apply to the management of other NCLs.

CLN2 disease-specific care can positively impact the quality of life of the child and the family.

Palliative care

This concept of care can be defined by the broader idea of supporting the body, spirit and mind of both the child and the family to optimise quality of life.1

  • Experts recommend discussions be initiated early, prior to physical and emotional exhaustion, with ongoing dialogue establishing trust with the palliative care team and ensuring parents’ goals are met
  • Home nursing can assist with everyday care to manage pain and prevent complications
  • Various types of hospice care can help provide respite for families, not just at the end of life
  • Family and individual therapy ranges from marriage and family to grief counselling, to help guide decision-making and plan for transitions as the disease progresses

Reference: 1. Williams RE et al. Management Strategies for CLN2 Disease. Pediatr Neurol 2017;69:102–112.